Mafalda Sobral
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mafalda Sobral has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Américo Martins
Hepato-Biliary-Pancreatic and Transplantation Centre, Curry Cabral Hospital, Lisbon Central Hospitals Centre, Lisbon, Portugal
2 shared publications- Eduardo Barroso
Serviço de Cirurgia Geral. Hospital de Curry Cabral. Centro Hospitalar de Lisboa Central. Lisboa. Portugal
2 shared publications - Hugo Pinto Marques
Hepato-Biliary-Pancreatic and Transplantation Centre, Curry Cabral Hospital/Local Health Unit of São José, and NOVA Medical School, Lisbon, Portugal
2 shared publications - Silvia Silva
Department of Surgery, Curry Cabral Hospital, Lisbon, Portugal
2 shared publications - Vasco Ribeiro
Serviço de Cirurgia Geral. Hospital de Curry Cabral. Centro Hospitalar de Lisboa Central. Lisboa. Portugal
2 shared publications Ana Nobre
CHBPT – Hospital Curry Cabral, Portugal
1 shared publication
Latest Publications
- 1 June 2021
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 299 (3) , 715-724
BestFLR Trial: Liver Regeneration at CT before Major Hepatectomies for Liver Cancer—A Randomized Controlled Trial Comparing Portal Vein Embolization with N-Butyl-Cyanoacrylate Plus Iodized Oil versus Polyvinyl Alcohol Particles Plus Coils
Portal vein embolization with N-butyl-cyanoacrylate plus iodized oil generates greater and faster liver regeneration as seen at CT compared with standard polyvinyl alcohol particles plus coils, all... Background In patients with liver cancer, portal vein embolization (PVE) is recommended to promote liver growth before major hepatectomies. However, the optimal embolization strategy has not been e...
- 1 June 2021
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 299 (3) , 715-724
BestFLR Trial: Liver Regeneration at CT before Major Hepatectomies for Liver Cancer—A Randomized Controlled Trial Comparing Portal Vein Embolization with N-Butyl-Cyanoacrylate Plus Iodized Oil versus Polyvinyl Alcohol Particles Plus Coils
Portal vein embolization with N-butyl-cyanoacrylate plus iodized oil generates greater and faster liver regeneration as seen at CT compared with standard polyvinyl alcohol particles plus coils, all... Background In patients with liver cancer, portal vein embolization (PVE) is recommended to promote liver growth before major hepatectomies. However, the optimal embolization strategy has not been e...
- 1 November 2015
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 262 (5) , 749-756
Long-term Results of Domino Liver Transplantation for Hepatocellular Carcinoma Using the “Double Piggy-back” Technique
Objectives: The aim of this study was to evaluate the long-term outcome of liver transplantation (LT) for hepatocellular carcinoma (HCC) with Domino LT (DLT) using the “Double Piggy-back” technique. Background data: DLT using livers from familial amyloidotic polyneuropathy (FAP) patients is a well-described technique and useful for expanding the donor pool. However, data on long-term results for HCC are limited, particularly regarding the use of the “Double Piggy-back” technique. Methods: Between 2001 and 2014, a total of 260 patients undergoing LT for HCC were analyzed from a prospective database. Of those, 114 were submitted to DLT. Comparisons between groups were performed using propensity score matching. Results: Median follow-up was 34 months (1–152). Overall and disease-free 5-year survival rates for the whole population were 58% and 56%, respectively. There were 177 (68%) patients within Milan Criteria and an additional 26 (10%) within University of California San Francisco (UCSF) criteria. Patients older than 50 years were more likely to receive an FAP liver [odds ratio (OR) 1.94, confidence interval (CI) 1.02–3.69]. DLT patients had more major complications (23.7% vs 13.0%, P = 0.025). Only patients undergoing DLT presented with piggy-back syndrome (7% vs 0%, P = 0.001). After adjusting for potential confounders, DLT and cadaveric LT had a similar 5-year survival rate (59% vs 44%, respectively, P = 0.117). Thirteen patients (11.4%) evidenced FAP disease but not before 6 years after DLT. Conclusions: DLT for HCC is feasible and achieves equivalent results to cadaveric LT. The benefit of expanding the donor pool must be balanced against higher morbidity and a real risk of disease transmission.
- 1 November 2015
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 262 (5) , 749-756
Long-term Results of Domino Liver Transplantation for Hepatocellular Carcinoma Using the “Double Piggy-back” Technique
Objectives: The aim of this study was to evaluate the long-term outcome of liver transplantation (LT) for hepatocellular carcinoma (HCC) with Domino LT (DLT) using the “Double Piggy-back” technique. Background data: DLT using livers from familial amyloidotic polyneuropathy (FAP) patients is a well-described technique and useful for expanding the donor pool. However, data on long-term results for HCC are limited, particularly regarding the use of the “Double Piggy-back” technique. Methods: Between 2001 and 2014, a total of 260 patients undergoing LT for HCC were analyzed from a prospective database. Of those, 114 were submitted to DLT. Comparisons between groups were performed using propensity score matching. Results: Median follow-up was 34 months (1–152). Overall and disease-free 5-year survival rates for the whole population were 58% and 56%, respectively. There were 177 (68%) patients within Milan Criteria and an additional 26 (10%) within University of California San Francisco (UCSF) criteria. Patients older than 50 years were more likely to receive an FAP liver [odds ratio (OR) 1.94, confidence interval (CI) 1.02–3.69]. DLT patients had more major complications (23.7% vs 13.0%, P = 0.025). Only patients undergoing DLT presented with piggy-back syndrome (7% vs 0%, P = 0.001). After adjusting for potential confounders, DLT and cadaveric LT had a similar 5-year survival rate (59% vs 44%, respectively, P = 0.117). Thirteen patients (11.4%) evidenced FAP disease but not before 6 years after DLT. Conclusions: DLT for HCC is feasible and achieves equivalent results to cadaveric LT. The benefit of expanding the donor pool must be balanced against higher morbidity and a real risk of disease transmission.
- Open Access
- 1 June 2015
- Published by American Medical Association (AMA) in JAMA Surgery
- Vol. 150 (6) , 577-584
Presentation and Clinical Outcomes of Choledochal Cysts in Children and Adults
First reported by Vater and Ezler1 in 1723, choledochal cysts (CCs) are rare cystic dilations of the biliary tract. Choledochal cysts are diagnosed in children and adults, although most (80%) develop in children younger than 10 years.2 Choledochal cysts are also 4 times more common in females than males. There is a higher incidence of CCs in Asian populations compared with other ethnicities,2,3 ranging from 1 in 100 000 Western individuals to 1 in 13 000 people within the Japanese population.4,5 The exact cause of CCs is unknown; however, in 1969, Babbitt6 first described the reflux of pancreatic enzymes into the biliary tree through an anomalous pancreaticobiliary duct union (APBDU), thereby leading to biliary dilation. Although rare in the general population, APBDU has been reported7,8 in more than 80% of children with CCs.
- 1 June 2015
- Published by American Medical Association (AMA) in JAMA Surgery
- Vol. 150 (6) , 577-584
Open AccessPresentation and Clinical Outcomes of Choledochal Cysts in Children and Adults
First reported by Vater and Ezler1 in 1723, choledochal cysts (CCs) are rare cystic dilations of the biliary tract. Choledochal cysts are diagnosed in children and adults, although most (80%) develop in children younger than 10 years.2 Choledochal cysts are also 4 times more common in females than males. There is a higher incidence of CCs in Asian populations compared with other ethnicities,2,3 ranging from 1 in 100 000 Western individuals to 1 in 13 000 people within the Japanese population.4,5 The exact cause of CCs is unknown; however, in 1969, Babbitt6 first described the reflux of pancreatic enzymes into the biliary tree through an anomalous pancreaticobiliary duct union (APBDU), thereby leading to biliary dilation. Although rare in the general population, APBDU has been reported7,8 in more than 80% of children with CCs.
- 1 June 2015
- Published by Elsevier in Pancreatology
- Vol. 15 (3) , S90
Pancreatic resection for intraductal papillary mucinous neoplasia – Experience of a decade
- 1 June 2015
- Published by Elsevier in Pancreatology
- Vol. 15 (3) , S90
Pancreatic resection for intraductal papillary mucinous neoplasia – Experience of a decade